Digital Media Center
Bryant-Denny Stadium, Gate 61
920 Paul Bryant Drive
Tuscaloosa, AL 35487-0370
(800) 654-4262

© 2023 Alabama Public Radio
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations
WAPR is operating at limited power. Thank you for your patience while we look into the issue.

Alabama to get limited supply of new anti-viral COVID-19 drug


Health officials say Alabama will be getting Pfizer’s new 5-day COVID-19 anti-viral drug. But, that supply will be limited to 780 courses of treatment. The FDA approved use the new drug, called Paxlovid, and Pfizer says it can start delivery as soon as this weekend to treat COVID-19. Public Health official say the oral drug Paxlovid will be distributed through pharmacies. The Food and Drug Administration approved it for emergency use in adults and children. Health officials say they're worried the state's health system will be strained as the fast-spreading omicron variant takes hold in Alabama. Hospitalizations for COVID-19 have jumped more than 70% statewide in a month. There’s also a concern over what treatments will work against the new omicron variant. Health care providers say certain treatments, like monoclonal antibodies are ineffective in treating the highly contagious type of COVID-19.

Pat Duggins is news director for Alabama Public Radio.
Related Content
News from Alabama Public Radio is a public service in association with the University of Alabama. We depend on your help to keep our programming on the air and online. Please consider supporting the news you rely on with a donation today. Every contribution, no matter the size, propels our vital coverage. Thank you.